Companies›Services›Services›Commercial Services & Supplies

Evoq Remedies Limited

Services › Commercial Services & Supplies
₹1.61
at close · 28 Oct 2026
▼ 0.08 (-4.73%)

Latest filings

  1. RTA Compliance Certificate for Quarter Ended September 2026 · Compliance
  2. Evoq Remedies gets one-month extension to hold AGM due to CIRP · Board & Shareholder Meetings
  3. Trading Window Closed for Half-Yearly Results · Compliance
All filings ↓
Ask Nexa about Evoq Remedies Limited

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

A small agro-commodity trading firm based in Ahmedabad, classified under Services / Trading & Distributors. Revenue from operations stood at Rs 25.51 crore in FY26, with the H1 FY26 figure more than doubling to Rs 2,550.68 lakhs from Rs 1,175.67 lakhs in H1 FY25. Despite the top-line growth, the company swung to a net loss of Rs 25.10 lakhs in FY26 from a profit in FY25, and the statutory auditor issued a qualified opinion with a material uncertainty related to going concern, citing curtailed operations and minimal revival prospects. Cost structure in FY26 was dominated by other operating expenses at 5.5% of revenue, with employee costs at 0.3% of revenue and materials at 0%; total assets stood at Rs 51.94 crore at year-end. In June 2026, the National Company Law Tribunal admitted a Corporate Insolvency Resolution Process against the company following an application by an operational creditor, and an Interim Resolution Professional is to be appointed. The auditor also flagged Rs 668.86 lakhs of related-party loans extended without proper approvals, Rs 1,251.18 lakhs of unconfirmed supplier advances, and a Rs 655.03 lakh GST demand under litigation. Promoters sold nearly their entire stakes through open-market transactions in October 2025.

Operating scale
Revenue from operations
Rs 25.51 croreFY26
Total assets
Rs 51.94 croreFY26
H1 FY26 revenue growth YoY
117%H1 FY26
Net loss
Rs 25.10 lakhsFY26
Other operating expenses
5.5% of revenueFY26
Related-party loans flagged by auditor
Rs 668.86 lakhsH1 FY26
Who pays it
Trading counterparties in agro-commodities (not specified in filings)
Biggest cost
Other operating expenses at 5.5% of revenue in FY26
Kind of business
Small, distressed trading firm under insolvency resolution
Where it sits
Small agro-commodity trader listed on BSE with FY26 revenue of Rs 25.51 crore
Market Cap
₹4 Cr
P / E (TTM)
1.9×
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
2.4%·
ROCE (5y median)
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed
Revenue FY22→FY26
1.5×▲
Revenue change
₹17 Cr → ₹26 Cr
Moves on a normal day
3.35%·
Median daily move
Last 260 sessions · the yardstick for filing-day moves
Where it sits among 188 Trading & Distributors peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#11/130
ROCE#137/177
Revenue growth#127/135

Scorecard

Measured from the filed financials, judged against its Trading & Distributors peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Returns on capital 2.4% (5-year median)
#137 of 177 in Trading & Distributors on the latest reported figures · down from 6.3% in FY22

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from Evoq Remedies Limited's filed financials and exchange disclosures

What does Evoq Remedies Limited do?

Evoq Remedies Limited is a Commercial Services & Supplies company listed on BSE.

Is Evoq Remedies Limited expensive compared with its peers?

On trailing P/E, Evoq Remedies Limited ranks 11 of 130 in Trading & Distributors — cheaper than 92% of them, against an industry median of 13.9×. This is a position, not a valuation judgement.

How much does the Evoq Remedies Limited share price move in a day?

On a typical session Evoq Remedies Limited moves 3.35% — that is the median absolute close-to-close move across its last 260 trading days. MarketPing measures each filing's price reaction against it.

Where can I track Evoq Remedies Limited's announcements?

Every NSE and BSE filing by Evoq Remedies Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.